These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 24598244

  • 1. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P.
    Diabetes Care; 2014 Jun; 37(6):1675-80. PubMed ID: 24598244
    [Abstract] [Full Text] [Related]

  • 2. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response.
    Tavira B, Cheramy M, Axelsson S, Åkerman L, Ludvigsson J, Casas R.
    Diabetologia; 2017 Jul; 60(7):1276-1283. PubMed ID: 28357504
    [Abstract] [Full Text] [Related]

  • 3. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z, LADA China Study Group.
    Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
    Huang G, Yin M, Xiang Y, Li X, Shen W, Luo S, Lin J, Xie Z, Zheng P, Zhou Z.
    Diabetes Metab Res Rev; 2016 Sep; 32(6):615-22. PubMed ID: 26787598
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
    Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E, Achenbach P.
    Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
    Elding Larsson H, Lundgren M, Jonsdottir B, Cuthbertson D, Krischer J, DiAPREV-IT Study Group.
    Pediatr Diabetes; 2018 May; 19(3):410-419. PubMed ID: 29171140
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.
    Skoglund C, Chéramy M, Casas R, Ludvigsson J, Hampe CS.
    Pediatr Diabetes; 2012 May; 13(3):244-50. PubMed ID: 21848927
    [Abstract] [Full Text] [Related]

  • 11. A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
    Hals IK, Balasuriya C, Casas R, Ludvigsson J, Björklund A, Grill V.
    Diabetes Obes Metab; 2023 Nov; 25(11):3400-3409. PubMed ID: 37580967
    [Abstract] [Full Text] [Related]

  • 12. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults.
    Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A.
    Diabetes Res Clin Pract; 2024 Sep; 215():111799. PubMed ID: 39084295
    [Abstract] [Full Text] [Related]

  • 13. GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response.
    Chéramy M, Skoglund C, Johansson I, Ludvigsson J, Hampe CS, Casas R.
    Clin Immunol; 2010 Oct; 137(1):31-40. PubMed ID: 20580618
    [Abstract] [Full Text] [Related]

  • 14. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P, Ambrosova P, Canov P, Weberova D, Kuklinek P, Meluzinova H, Matejovska-Kubesova H, Cejkova P, Bielakova K, Cerna M.
    Adv Gerontol; 2011 Oct; 24(2):312-8. PubMed ID: 21957594
    [Abstract] [Full Text] [Related]

  • 15. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E, Okada A, Uchida A, Fukuyama T, Sagara Y, Nakano Y, Tamai H, Tojikubo M, Koga N.
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [Abstract] [Full Text] [Related]

  • 16. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, Huang G, Zhou Z, Liu Y.
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [Abstract] [Full Text] [Related]

  • 17. GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
    Maruyama T, Oak S, Shimada A, Hampe CS.
    Diabetes Care; 2008 Aug; 31(8):1602-7. PubMed ID: 18487477
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 Aug; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

  • 19. Therapy with GAD in diabetes.
    Ludvigsson J.
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [Abstract] [Full Text] [Related]

  • 20. GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination.
    Bekris LM, Jensen RA, Lagerquist E, Hall TR, Agardh CD, Cilio CM, Lethagen AL, Lernmark A, Robertson JA, Hampe CS.
    Diabet Med; 2007 May; 24(5):521-6. PubMed ID: 17367313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.